ROS-responsive multilamellar liposomal vesicles for targeting inflammatory macrophages

Provided herein are liposomal vesicles comprising at least a first lipid bilayer and a second lipid bilayer, and a plurality of crosslinkages between the first lipid bilayer and the second lipid bilayer, wherein the plurality of crosslinkages comprise boronic ester or thioketal bonds. Also provided...

Full description

Saved in:
Bibliographic Details
Main Authors Morton, Stephen, Wang, Zhan
Format Patent
LanguageEnglish
Published 10.03.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Provided herein are liposomal vesicles comprising at least a first lipid bilayer and a second lipid bilayer, and a plurality of crosslinkages between the first lipid bilayer and the second lipid bilayer, wherein the plurality of crosslinkages comprise boronic ester or thioketal bonds. Also provided are pharmaceutical compositions comprising the liposomal vesicles described herein and a pharmaceutically acceptable excipient. Also provided are methods of making and using the liposomal vesicles. Thus, a method of treating a subject with a disease comprising administering to the subject a pharmaceutical composition comprising the liposomal vesicles is described herein. Methods of making multilamellar liposomal vesicles responsive to reactive oxygen species are also provided.
AbstractList Provided herein are liposomal vesicles comprising at least a first lipid bilayer and a second lipid bilayer, and a plurality of crosslinkages between the first lipid bilayer and the second lipid bilayer, wherein the plurality of crosslinkages comprise boronic ester or thioketal bonds. Also provided are pharmaceutical compositions comprising the liposomal vesicles described herein and a pharmaceutically acceptable excipient. Also provided are methods of making and using the liposomal vesicles. Thus, a method of treating a subject with a disease comprising administering to the subject a pharmaceutical composition comprising the liposomal vesicles is described herein. Methods of making multilamellar liposomal vesicles responsive to reactive oxygen species are also provided.
Author Morton, Stephen
Wang, Zhan
Author_xml – fullname: Morton, Stephen
– fullname: Wang, Zhan
BookMark eNqNzU0KwjAQQOEsdOHfHcYDFFqK0LWiuBOsui1DmbSBSSZkYsHb24UHcPU2H7y1WQQJtDKv-60tEmmUoG4i8G_OjtETMyZgF0XFI8NE6nomBSsJMqaBsgsDuGBn7DFL-oDHPkkccSDdmqVFVtr9ujH7y_lxuhYUpZtv2FOg3D3bqjw0ddnUx6r-x3wB-388wA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US10583083B1
GroupedDBID EVB
ID FETCH-epo_espacenet_US10583083B13
IEDL.DBID EVB
IngestDate Fri Jul 19 15:15:35 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US10583083B13
Notes Application Number: US201715672589
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200310&DB=EPODOC&CC=US&NR=10583083B1
ParticipantIDs epo_espacenet_US10583083B1
PublicationCentury 2000
PublicationDate 20200310
PublicationDateYYYYMMDD 2020-03-10
PublicationDate_xml – month: 03
  year: 2020
  text: 20200310
  day: 10
PublicationDecade 2020
PublicationYear 2020
RelatedCompanies Verily Life Sciences LLC
RelatedCompanies_xml – name: Verily Life Sciences LLC
Score 3.1763294
Snippet Provided herein are liposomal vesicles comprising at least a first lipid bilayer and a second lipid bilayer, and a plurality of crosslinkages between the first...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title ROS-responsive multilamellar liposomal vesicles for targeting inflammatory macrophages
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200310&DB=EPODOC&locale=&CC=US&NR=10583083B1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp6LzgwjSt2C3fix7GMLalSHsg32xt5HWBCdrO9Y6_30vsXO-6FtpS0guuftdcr-7ADyGjZqq8hZShsuFIl5blLnSptI1lXseMamj572-253aL3NnXoL3XS6MrhP6qYsjokZFqO-5ttfr_SGWr7mV2VO4xFfpczBp-UaxO67rSpeG3251hgN_4Bme15qOjf4IfV2HWehutHGndFB3LFfR_zqztspKWf-GlOAUDofYWpKfQUkkFTj2djevVeCoVwS88bHQvewcZqPBmG4KSutWEE0FxPlU9KUNWS3XaZbGfEW2ItNUN4LuKPkmeiM8EVxJ-HOsg-ok5urmrje0JdkFPASdidel2MHFjzQW0_F-LNYllJM0EVdAmlHERLOB5so2bcEl56-mKxGBec1yQsmuofp3O9X_Pt7AiZIs1SS2Wyjnmw9xh0ich_dahF_CH497
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOKbokbxqyZmb43DjTEeFpN9EFTYCAPCG9lGFzGwETbx3_dah_iib03bNO2td7_r7tcrwH3YrPMsbyHVcbtQxGuF6lqs0liTuXse6bGInvdcrTNSXyaNSQnet3dhRJ7QT5EcETUqQn3Phb1e7X5i2YJbmT2Ec6xKn9pDw5aK0_GjyHQp2abh9D3bsyTLMka-5A7Q123oCrobJp6U9lCnZE7_c8Ymv5Wy-g0p7SPY7-NoSX4MJZZUoWJtX16rwkGvCHhjsdC97ATGA8-n64LSumFEUAHxe3L60pos5qs0S5fBgmxYJqhuBN1R8k30RngiuJOw81IE1cky4C93vaEtyU7hru0MrQ7FCU5_pDEd-bu1KGdQTtKEnQNpRZHOWk00V6qssiAOgpmsxYjAQV1phLF-AbW_x6n913gLlc6w1512n93XSzjkUqaC0HYF5Xz9wa4RlfPwRojzC52DkmU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ROS-responsive+multilamellar+liposomal+vesicles+for+targeting+inflammatory+macrophages&rft.inventor=Morton%2C+Stephen&rft.inventor=Wang%2C+Zhan&rft.date=2020-03-10&rft.externalDBID=B1&rft.externalDocID=US10583083B1